On Tuesday, Acelyrin Inc (NASDAQ: SLRN) opened higher 2.63% from the last session, before settling in for the closing price of $2.28. Price fluctuations for SLRN have ranged from $1.85 to $7.25 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 40.53% at the time writing. With a float of $73.15 million, this company’s outstanding shares have now reached $100.45 million.
The firm has a total of 83 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Acelyrin Inc (SLRN) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Acelyrin Inc is 27.51%, while institutional ownership is 75.91%. The most recent insider transaction that took place on Mar 17 ’25, was worth 49,354. In this transaction Chief Executive Officer of this company sold 17,986 shares at a rate of $2.74, taking the stock ownership to the 671,753 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Chief Legal Officer sold 3,913 for $2.74, making the entire transaction worth $10,737. This insider now owns 121,587 shares in total.
Acelyrin Inc (SLRN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.53% per share during the next fiscal year.
Acelyrin Inc (NASDAQ: SLRN) Trading Performance Indicators
Check out the current performance indicators for Acelyrin Inc (SLRN). In the past quarter, the stock posted a quick ratio of 18.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50 and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Acelyrin Inc (SLRN)
Analysing the last 5-days average volume posted by the [Acelyrin Inc, SLRN], we can find that recorded value of 0.81 million was lower than the volume posted last year of 1.99 million. As of the previous 9 days, the stock’s Stochastic %D was 62.49%. Additionally, its Average True Range was 0.16.
During the past 100 days, Acelyrin Inc’s (SLRN) raw stochastic average was set at 15.57%, which indicates a significant decrease from 34.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.01% in the past 14 days, which was lower than the 103.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.45, while its 200-day Moving Average is $4.03. Now, the first resistance to watch is $2.37. This is followed by the second major resistance level at $2.40. The third major resistance level sits at $2.45. If the price goes on to break the first support level at $2.29, it is likely to go to the next support level at $2.24. Should the price break the second support level, the third support level stands at $2.21.
Acelyrin Inc (NASDAQ: SLRN) Key Stats
There are currently 100,907K shares outstanding in the company with a market cap of 236.12 million. Presently, the company’s annual sales total 0 K according to its annual income of -248,230 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -79,030 K.
